Literature DB >> 34175235

A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.

Ayse Sahin Tutak1, Fatih Söylemez2, Hazal B Konuk2, Erkan Çakmak2, Bülent Karakaya2, Ali Doğan2, Hakan S Sayiner3, Selçuk Aksöz3, Mehtap Alev3.   

Abstract

COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A against SARS-CoV-2 was admitted to our intensive care unit (ICU) due to the clinical picture of Acute Respiratory Distress Syndrome (ARDS). We aimed to stress the need for continuing preventive measures in vaccinated individuals, too, by presenting the clinical findings of the patient, who was considered to have developed ARDS due to COVID-19, as high levels of IgG and IgM-A against SARS-CoV-2 were detected on day 8 during ICU admission.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M

Year:  2021        PMID: 34175235      PMCID: PMC8170910          DOI: 10.1016/j.jiph.2021.05.017

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  11 in total

1.  Discovering drugs to treat coronavirus disease 2019 (COVID-19).

Authors:  Liying Dong; Shasha Hu; Jianjun Gao
Journal:  Drug Discov Ther       Date:  2020

2.  Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.

Authors:  Raymond T Suhandynata; Melissa A Hoffman; Michael J Kelner; Ronald W McLawhon; Sharon L Reed; Robert L Fitzgerald
Journal:  J Appl Lab Med       Date:  2020-09-01

Review 3.  A Review of Coronavirus Disease-2019 (COVID-19).

Authors:  Tanu Singhal
Journal:  Indian J Pediatr       Date:  2020-03-13       Impact factor: 1.967

4.  Effective treatment of severe COVID-19 patients with tocilizumab.

Authors:  Xiaoling Xu; Mingfeng Han; Tiantian Li; Wei Sun; Dongsheng Wang; Binqing Fu; Yonggang Zhou; Xiaohu Zheng; Yun Yang; Xiuyong Li; Xiaohua Zhang; Aijun Pan; Haiming Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

5.  Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.

Authors:  Livia Mazzini; Donata Martinuzzi; Inesa Hyseni; Linda Benincasa; Eleonora Molesti; Elisa Casa; Giulia Lapini; Pietro Piu; Claudia Maria Trombetta; Serena Marchi; Ilaria Razzano; Alessandro Manenti; Emanuele Montomoli
Journal:  J Immunol Methods       Date:  2020-11-28       Impact factor: 2.303

6.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

Authors:  Jesús Villar; Carlos Ferrando; Domingo Martínez; Alfonso Ambrós; Tomás Muñoz; Juan A Soler; Gerardo Aguilar; Francisco Alba; Elena González-Higueras; Luís A Conesa; Carmen Martín-Rodríguez; Francisco J Díaz-Domínguez; Pablo Serna-Grande; Rosana Rivas; José Ferreres; Javier Belda; Lucía Capilla; Alec Tallet; José M Añón; Rosa L Fernández; Jesús M González-Martín
Journal:  Lancet Respir Med       Date:  2020-02-07       Impact factor: 30.700

7.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

8.  Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.

Authors:  Yafang Li; Lin Yao; Jiawei Li; Lei Chen; Yiyan Song; Zhifang Cai; Chunhua Yang
Journal:  J Med Virol       Date:  2020-04-05       Impact factor: 2.327

9.  Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak.

Authors:  Yishan Wang; Hanyujie Kang; Xuefeng Liu; Zhaohui Tong
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

10.  False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases.

Authors:  Dasheng Li; Dawei Wang; Jianping Dong; Nana Wang; He Huang; Haiwang Xu; Chen Xia
Journal:  Korean J Radiol       Date:  2020-03-05       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.